🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Impact of Bariatric Surgery and Liraglutide on Cognitive-Behavioral Markers of Long-Term Weight Loss in Obesity

Recruitingn/aAges 20 Years - 60 YearsAllI.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
NCT06720246 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The present research project aims to study the effects of bariatric surgery and liraglutide administration (in patients already selected for one of these procedures) on two cognitive-behavioral processes partially supported by distinct brain networks: automatic approach tendencies (underpinned by the cue-reactivity network) and behavioral inhibition (underpinned by the cue-regulation network). Additionally, the investigators aim to study how these processes may be modulated by satiety. The secondary objective of the project includes identifying cognitive-behavioral markers that can predict the response to these treatments.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Subjects of any ethnicity, aged between 20 and 60 years. * BMI equal to or greater than 30 kg/m². * No history of neurological or psychiatric disorders, as confirmed through medical history and neuropsychological screening. * Signed informed consent and willingness to comply with all study procedures. * Patients scheduled for surgery, treatment with liraglutide, or a dietary regimen. Exclusion Criteria: * Previous diagnosis of significant neurological conditions (e.g., brain injury or dementia) or major psychiatric disorders. * Current or past psychopharmacological therapy, if prolonged. * BMI lower than 30 kg/m². * Lack of signed informed consent. * Severe medical conditions, including but not limited to: hypertension, significant cardiac disease, or other disorders that may compromise patient safety. * Confirmed pregnancy through self-report and/or breastfeeding.
💊

What it tests

  • Not listed
📍

Where

1 site
IRCCS Ospedale Galeazzi-Sant'Ambrogio
Milan, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy